Skip to main content
NCBI home page
Scientific Reports logoLink to Scientific Reports
. 2020 Jan 31;10:1918. doi: 10.1038/s41598-020-58486-6

Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy

Annamaria Ruzzo 1,✉,#, Francesco Graziano 2,✉,#, Francesca Galli 3, Fabio Galli 3, Eliana Rulli 3, Sara Lonardi 4, Monica Ronzoni 5, Bruno Massidda 6, Vittorina Zagonel 4, Nicoletta Pella 7, Claudia Mucciarini 8, Roberto Labianca 9, Maria Teresa Ionta 6, Irene Bagaloni 1, Enzo Veltri 10, Pietro Sozzi 11, Sandro Barni 12, Vincenzo Ricci 5, Luisa Foltran 13, Mario Nicolini 14, Edoardo Biondi 15, Annalisa Bramati 16, Daniele Turci 17, Silvia Lazzarelli 18, Claudio Verusio 19, Francesca Bergamo 4, Alberto Sobrero 20, Luciano Frontini 21, Mauro Magnani 1
PMCID: PMC6994718  PMID: 32005869

Correction to: Scientific Reports 10.1038/s41598-019-47627-1, published online 08 August 2019

The original version of this Article contained an error in Affiliation 4, which was incorrectly given as ‘IOV- IRCCS, Padova, Italy’. The correct affiliation is listed below:

Istituto Oncologico Veneto IOV – IRCCS, Padova, Italy

This error has now been corrected in the HTML and PDF versions of the Article, and in the accompanying Supplemental Material.

Contributor Information

Annamaria Ruzzo, Email: annamaria.ruzzo@uniurb.it.

Francesco Graziano, Email: graziano.fda@yahoo.com.

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES